Signals · crescentbiopharma.com

What just happened at Crescent Biopharma

Last updated

Crescent Biopharma disclosed another material event (8-K items 8.01) on 2026-07-15. It was reported by sec.gov.

The evidence, dated and sourced

  1. — Funding: Crescent Biopharma disclosed another material event (8-K items 8.01).
    Press / news →
  2. — SEC 8-K: Crescent Biopharma, Inc. had a change in control (8-K item 5.01).
    SEC filing →
  3. — SEC 8-K: Crescent Biopharma, Inc. entered a material definitive agreement (8-K item 1.01).
    SEC filing →

How this is sourced

Every row above links to the document it came from — an SEC filing on EDGAR, or the announcement a publisher ran. Fundz does not paraphrase a source it has not stored, and each row is labelled sec_filing or press_or_news so you can see which you are reading. Funding rounds come from SEC Form D filings and announcements; 8-K events come from the filings themselves. No contact or people data appears here.

Companies with recent events

Get this via API or MCP

The same evidence, as JSON, for your own agents. Quickstart → · MCP endpoint https://api.fundz.net/v1/agent/mcp

curl -s -X POST https://api.fundz.net/v1/agent/why_now \
  -H "X-Fundz-Key: $FUNDZ_KEY" -H "Content-Type: application/json" \
  -d '{"domain": "crescentbiopharma.com"}'